185 related articles for article (PubMed ID: 16299232)
1. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma.
Cleton-Jansen AM; van Beerendonk HM; Baelde HJ; Bovée JV; Karperien M; Hogendoorn PC
Clin Cancer Res; 2005 Nov; 11(22):8028-35. PubMed ID: 16299232
[TBL] [Abstract][Full Text] [Related]
2. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
3. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitor exemestane has antiproliferative effects on human mesothelioma cells.
Stoppoloni D; Salvatori L; Biroccio A; D'Angelo C; Muti P; Verdina A; Sacchi A; Vincenzi B; Baldi A; Galati R
J Thorac Oncol; 2011 Mar; 6(3):583-91. PubMed ID: 21289517
[TBL] [Abstract][Full Text] [Related]
5. Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.
Mukhopadhyay KD; Liu Z; Bandyopadhyay A; Kirma NB; Tekmal RR; Wang S; Sun LZ
PLoS One; 2015; 10(4):e0121136. PubMed ID: 25837259
[TBL] [Abstract][Full Text] [Related]
6. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
[TBL] [Abstract][Full Text] [Related]
7. Aromatase expression in ovarian epithelial cancers.
Cunat S; Rabenoelina F; Daurès JP; Katsaros D; Sasano H; Miller WR; Maudelonde T; Pujol P
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):15-24. PubMed ID: 15748828
[TBL] [Abstract][Full Text] [Related]
8. Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo.
Meijer D; Gelderblom H; Karperien M; Cleton-Jansen AM; Hogendoorn PC; Bovee JV
Clin Sarcoma Res; 2011 Jul; 1(1):5. PubMed ID: 22613849
[TBL] [Abstract][Full Text] [Related]
9. Aromatase and breast cancer.
Brodie A; Sabnis G; Jelovac D
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):97-102. PubMed ID: 17113978
[TBL] [Abstract][Full Text] [Related]
10. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
Kijima I; Itoh T; Chen S
J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
[TBL] [Abstract][Full Text] [Related]
12. Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor.
Wang X; Chen S
Cancer Res; 2006 Nov; 66(21):10281-6. PubMed ID: 17079446
[TBL] [Abstract][Full Text] [Related]
13. Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane.
Miki Y; Suzuki T; Hatori M; Igarashi K; Aisaki KI; Kanno J; Nakamura Y; Uzuki M; Sawai T; Sasano H
Bone; 2007 Apr; 40(4):876-87. PubMed ID: 17254854
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of exemestane in lung cancer cells.
Koutras A; Giannopoulou E; Kritikou I; Antonacopoulou A; Evans TR; Papavassiliou AG; Kalofonos H
Mol Cancer; 2009 Nov; 8():109. PubMed ID: 19930708
[TBL] [Abstract][Full Text] [Related]
15. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
[TBL] [Abstract][Full Text] [Related]
16. Update on chondrosarcomas.
Chow WA
Curr Opin Oncol; 2007 Jul; 19(4):371-6. PubMed ID: 17545802
[TBL] [Abstract][Full Text] [Related]
17. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
[TBL] [Abstract][Full Text] [Related]
19. Estrogen synthesis in human colon cancer epithelial cells.
Fiorelli G; Picariello L; Martineti V; Tonelli F; Brandi ML
J Steroid Biochem Mol Biol; 1999 Dec; 71(5-6):223-30. PubMed ID: 10704911
[TBL] [Abstract][Full Text] [Related]
20. Estrogen signaling in cancer microenvironment and prediction of response to hormonal therapy.
Hayashi S; Yamaguchi Y
J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):201-6. PubMed ID: 18424035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]